The investment in Orthomed Medizinisches Leistungs- und Rehabilitationszentrum GmbH (33.33%) with its HGB financial statements as at 31 December 2022 is reported here.
EUR '000 |
|
30/06/2023 |
|
30/06/2022 |
|---|---|---|---|---|
|
|
|
|
|
Non-current assets |
|
562 |
|
520 |
Current assets |
|
869 |
|
831 |
Non-current liabilities |
|
204 |
|
160 |
Current liabilities |
|
222 |
|
232 |
Net assets |
|
1,005 |
|
959 |
Group’s share of net assets (33.33%) |
|
335 |
|
320 |
Goodwill |
|
59 |
|
59 |
Dividends received after 31 December 2022 |
|
0 |
|
0 |
Carrying amount of interest in associate |
|
394 |
|
379 |
Revenue |
|
4,485 |
|
4,432 |
Profit/loss from continuing operations |
|
46 |
|
181 |
Comprehensive income (33.33%) |
|
15 |
|
60 |
Group’s share of comprehensive income |
|
15 |
|
60 |
EUR '000 |
|
2022 |
|
2021 |
|---|---|---|---|---|
|
|
|
|
|
Cash flows from operating activities |
|
-6 |
|
21 |
Cash flows from investing activities |
|
-149 |
|
-67 |
Cash flows from financing activities |
|
35 |
|
-261 |
Net change in cash and cash equivalents |
|
-120 |
|
-307 |